Business

Neurometrix sells pain relief patch through crowdfunding site

14neurometrix - Dr. Shai Gozani, president and chief executive officer of NeuroMetrix, holds a wearable pain relief technology device called Quell while speaking during an interview at the Consumer Electronics Show Wednesday, Jan. 7, 2015, in Las Vegas. Quell, which is designed by Waltham-based NeuroMetrix, is assembled and manufactured in Massachusetts. (Ronda Churchill for The Boston Globe)

The Boston Globe

Dr. Shai Gozani, president and chief executive officer of NeuroMetrix, holds a wearable pain relief technology device called Quell at the Consumer Electronics Show Wednesday in Las Vegas.

NeuroMetrix will sell hundreds of wearable pain-relief devices through an unusual platform for a publicly traded company: the crowdfunding website Indiegogo.

Typically, Indiegogo is used by small-scale innovators looking to get a project off the ground. NeuroMetrix, a Waltham company, has stock that’s traded on the Nasdaq market and is worth about $13.4 million. The stock closed at $1.64 on Monday, up 1 percent.

Advertisement

Its over-the-counter product, the Quell, uses electrical pulses to trigger the release of pain-relieving endorphins and enkephalins by the brain. It might sound unusual, but it’s simply a consumer application of a nonaddictive therapy used by doctors that’s called transcutaneal electrical nerve stimulation, or TENS.

According to the product’s Indiegogo page, 1,000 devices will be made available to the site starting at $199 each, with some being sold as bundles. McGillin said the goal is to sell at least 500 of them. By 1 p.m. Monday, 279 devices had been sold.

Get Talking Points in your inbox:
An afternoon recap of the day’s most important business news, delivered weekdays.
Thank you for signing up! Sign up for more newsletters here

If demand outstrips the company’s present manufacturing capacity, McGillin said, “that would be a good problem to have.”

Shipments of the Quell begin this spring, McGillin said, and it will initially only be available online and through doctors’ offices.

The company has said that the device will be made in West Bridgewater.

Jack Newsham can be reached at jack.newsham@globe.com. Follow him on Twitter @TheNewsHam.
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.